Joseph W. Adelsberger

6.1k total citations · 2 hit papers
59 papers, 4.6k citations indexed

About

Joseph W. Adelsberger is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Joseph W. Adelsberger has authored 59 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Virology, 37 papers in Immunology and 17 papers in Infectious Diseases. Recurrent topics in Joseph W. Adelsberger's work include HIV Research and Treatment (43 papers), Immune Cell Function and Interaction (32 papers) and T-cell and B-cell Immunology (13 papers). Joseph W. Adelsberger is often cited by papers focused on HIV Research and Treatment (43 papers), Immune Cell Function and Interaction (32 papers) and T-cell and B-cell Immunology (13 papers). Joseph W. Adelsberger collaborates with scholars based in United States, France and United Kingdom. Joseph W. Adelsberger's co-authors include Michael Baseler, H. Clifford Lane, Anthony S. Fauci, Richard A. Lempicki, Richard T. Davey, Julia A. Metcalf, Robin Dewar, Joseph A. Kovacs, Tae‐Wook Chun and Michael A. Polis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Joseph W. Adelsberger

59 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1999 639 citations Richard T. Davey, Christian Yoder et al. Proceedings of the National Academy of Sciences profile →
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV

1994 503 citations Joseph W. Adelsberger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph W. Adelsberger United States	34	3.0k	2.6k	1.5k	1.1k	491	59	4.6k
Sigrid A. Otto Netherlands	29	2.6k 0.8×	3.1k 1.2×	1.1k 0.7×	1.1k 1.0×	504 1.0×	55	4.8k
James F. Demarest United States	25	3.9k 1.3×	2.7k 1.0×	2.0k 1.3×	1.2k 1.1×	418 0.9×	46	5.1k
Linda A. Ehler United States	26	4.4k 1.5×	3.0k 1.1×	2.2k 1.4×	1.0k 0.9×	469 1.0×	28	5.2k
Florencia Pereyra United States	44	4.2k 1.4×	3.7k 1.4×	1.8k 1.2×	1.1k 1.0×	905 1.8×	74	6.1k
Lydie Trautmann United States	25	2.6k 0.9×	2.8k 1.1×	1.5k 1.0×	1.0k 0.9×	630 1.3×	58	4.7k
Rémi Fromentin Canada	36	3.4k 1.1×	1.8k 0.7×	1.9k 1.3×	873 0.8×	652 1.3×	69	4.2k
Rémi Cheynier France	35	2.9k 1.0×	2.2k 0.8×	1.6k 1.0×	1.1k 1.0×	610 1.2×	85	4.5k
Gianfranco Pancino France	35	3.4k 1.1×	2.6k 1.0×	1.4k 0.9×	1.3k 1.2×	925 1.9×	100	4.8k
Bader Yassine‐Diab Canada	23	2.3k 0.7×	2.1k 0.8×	1.2k 0.8×	702 0.6×	554 1.1×	35	3.5k
Charles Farthing United States	22	3.0k 1.0×	1.7k 0.6×	1.9k 1.3×	1.1k 1.0×	373 0.8×	46	4.0k

Countries citing papers authored by Joseph W. Adelsberger

Since Specialization

Citations

This map shows the geographic impact of Joseph W. Adelsberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph W. Adelsberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph W. Adelsberger more than expected).

Fields of papers citing papers by Joseph W. Adelsberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph W. Adelsberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph W. Adelsberger. The network helps show where Joseph W. Adelsberger may publish in the future.

Co-authorship network of co-authors of Joseph W. Adelsberger

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph W. Adelsberger. A scholar is included among the top collaborators of Joseph W. Adelsberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph W. Adelsberger. Joseph W. Adelsberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imamichi, Tomozumi, Jun Yang, Qian Chen, et al.. (2025). Interleukin-27-polarized HIV-resistant M2 macrophages are a novel subtype of macrophages that express distinct antiviral gene profiles in individual cells: implication for the antiviral effect via different mechanisms in the individual cell-dependent manner. Frontiers in Immunology. 16. 1550699–1550699. 2 indexed citations

Oguariri, Raphael M., et al.. (2022). Short Communication: S100A8 and S100A9, Biomarkers of SARS-CoV-2 Infection and Other Diseases, Suppress HIV Replication in Primary Macrophages. AIDS Research and Human Retroviruses. 38(5). 401–405. 6 indexed citations

Wilson, Eleanor, M. Schechter, Catherine W. Cai, et al.. (2021). High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era. Journal of Virus Eradication. 7(3). 100052–100052. 2 indexed citations

Poudyal, Deepak, Jun Yang, Qian Chen, et al.. (2019). IL-27 posttranslationally regulates Y-box binding protein-1 to inhibit HIV-1 replication in human CD4+ T cells. AIDS. 33(12). 1819–1830. 14 indexed citations

Zhou, Xueyuan, Zhu Liu, Jun Zhang, et al.. (2016). Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes. BMC Microbiology. 16(1). 172–172. 22 indexed citations

Yang, Jun, Norma C. Serrano, Joseph W. Adelsberger, et al.. (2016). The effects of storage temperature on PBMC gene expression. BMC Immunology. 17(1). 6–6. 60 indexed citations

Imamichi, Hiromi, Ven Natarajan, Joseph W. Adelsberger, et al.. (2014). Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS. 28(8). 1091–1099. 47 indexed citations

Hahn, Barbara, Catherine Rehm, Joseph W. Adelsberger, et al.. (2008). The Effect of Continuous Versus Pericycle Antiretroviral Therapy on IL-2 Responsiveness. Journal of Interferon & Cytokine Research. 28(7). 455–462. 1 indexed citations

Pascal, Véronique, Eriko Yamada, Maureen P. Martin, et al.. (2007). Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection. The Journal of Immunology. 179(3). 1625–1633. 43 indexed citations

10.

Harris, Erik, Constance J. Glover, Joseph W. Adelsberger, et al.. (2006). A sterol mesylate activator of CEBPα signaling induces monocytic differentiation in human leukemia cells in vitro and in vivo. Cancer Research. 66. 1085–1085. 3 indexed citations

11.

Lempicki, Richard A., Robert J. Gorelick, Jun Yang, et al.. (2006). Noninfectious papilloma virus–like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood. 109(5). 1841–1849. 87 indexed citations

12.

Quinto, Ileana, Jack Greenhouse, Peter Silvera, et al.. (2004). High Attenuation and Immunogenicity of a Simian Immunodeficiency Virus Expressing a Proteolysis-resistant Inhibitor of NF-κB. Journal of Biological Chemistry. 279(3). 1720–1728. 6 indexed citations

13.

Kinter, Audrey, Craig A. Umscheid, James Arthos, et al.. (2003). HIV Envelope Induces Virus Expression from Resting CD4+ T Cells Isolated from HIV-Infected Individuals in the Absence of Markers of Cellular Activation or Apoptosis. The Journal of Immunology. 170(5). 2449–2455. 41 indexed citations

14.

Pinto, Lígia A., Philip E. Castle, Clayton Harro, et al.. (2003). Cellular Immune Responses to Human Papillomavirus (HPV)–16 L1 in Healthy Volunteers Immunized with Recombinant HPV‐16 L1 Virus‐Like Particles. The Journal of Infectious Diseases. 188(2). 327–338. 140 indexed citations

15.

Moir, Susan, Angela Malaspina, Kisani M. Ogwaro, et al.. (2001). HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proceedings of the National Academy of Sciences. 98(18). 10362–10367. 242 indexed citations

16.

Kovacs, Joseph A., Susan Vogel, Randy Stevens, et al.. (2001). Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. European Journal of Immunology. 31(5). 1351–1360. 48 indexed citations

17.

Douek, Daniel C., Michael R. Betts, Brenna J. Hill, et al.. (2001). Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection. The Journal of Immunology. 167(11). 6663–6668. 192 indexed citations

18.

Kovacs, Joseph A., Richard A. Lempicki, Igor A. Sidorov, et al.. (2001). Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV. The Journal of Experimental Medicine. 194(12). 1731–1741. 181 indexed citations

19.

Kovacs, Joseph A., Hiromi Imamichi, Susan Vogel, et al.. (2000). Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression. The Journal of Infectious Diseases. 182(4). 1063–1069. 25 indexed citations

20.

Koenig, Scott, Robert M. Woods, Yambasu A. Brewah, et al.. (1993). Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.. The Journal of Immunology. 151(7). 3874–3883. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact